Concepedia

Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours

Vanesa Gregorc, Giovanni Citterio, Giordano Vitali, Anna Spreafico, Paola Scifo, A Borri, Giovanni Donadoni, Gilda Rossoni, Angelo Corti, Federico Caligaris‐Cappio,

European Journal of Cancer · 2009 · 53 citations · 19 references

DOI

Concepts

References

19

An endotoxin-induced serum factor that causes necrosis of tumors.

E A Carswell, Lloyd J. Old, Robert Kassel et al. · Proceedings of the National Academy of Sciences · 1975 · 4.5K citations · Full text

, , +15

Enhancement of tumor necrosis factor α antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)

Flavio Curnis, Angelina Sacchi, Laura Borgna et al. · Nature Biotechnology · 2000 · 417 citations

, , +10

Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells.

Flavio Curnis, Gianluigi Arrigoni, Angelina Sacchi et al. · PubMed · 2002 · 279 citations

, , +14

Efficiency of recombinant human TNF in human cancer therapy.

Ferdy J. Lejeune, Danielle Líénard, Maurice Matter et al. · PubMed · 2006 · 263 citations

, , +17

Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration

Flavio Curnis, Angelina Sacchi, Angelo Corti · Journal of Clinical Investigation · 2002 · 238 citations · Full text

, , +17